The Phacilitate Cell & Gene Therapy Forum celebrates its 10th Birthday in Washington, DC this coming January, 27th-29th. We will mark the occasion by delivering the biggest and best event in the series’ history.

Building on a record attendance in 2013 (more than 350 of the most senior decision-makers in the cell therapy, gene therapy and tissue engineered product sectors) we will welcome our largest ever speaker to the event – more than 100 of the most influential payers, regulators, investors, big pharma cheque-writers and, of course, the leading lights of the global cell & gene therapy industry itself.

And brand new for 2014, we will feature a stream dedicated to Stem Cells for Discovery Research, driving even more attendees from major pharma and biotech companies to the event.

As in previous years, the event will be collocated with the Washington Vaccine Forum. However, this conference transforms into the Phacilitate Vaccine & Immunotherapy Forum in 2014, meaning greater synergy with the Cell & Gene Therapy Forum through dedicated coverage of cell-based immunotherapy and other therapeutic vaccine technologies.

We expect to welcome 500-600 attendees in total to our Washington 2014 meeting, with all networking shared and every conference session available to each attendee. PLUS delegates will receive access to an online pre-event Partnering Service, allowing them to contact individuals and organise meetings before they arrive onsite.

Visit us again soon for updates on the agenda and confirmed speaker panel. In the meantime, register your interest in attending the event as a delegate here or receive information on already-limited remaining sponsorship and exhibition opportunities by contacting Michael Adeniya, Business Development Director (Michael@phacilitate.co.uk; +44 (0)20 7384 7951).